-
Effect of dispersant structure and dosage on the performance of latex paint (2)
Time of Update: 2021-01-21
1 shows that of the 3 dispersants selected, the S110 preparation coating has the smallest color difference and the best water resistance before and after immersion under the premise of the same dosage.
-
End of 2020: SARS-CoV-2 important research results interpretation!
Time of Update: 2021-01-21
outbreak swept the world. Contagious and lethal, however, the researchers found the opposite results in this study, in which they analyzed a particular mutation that makes SARS-CoV-2 less pathogenic, resulting in a lower immune response, less
-
Sichuan pharmaceutical companies impact 2 billion varieties of the first over-evaluation only one has been approved by domestic
Time of Update: 2021-01-21
On November 13, CDE official website data show that Sichuan Guo for the pharmaceutical osteochemical triol softgel class 4 imitation market application was accepted, is currently in review and approval. is a top1 variety of vitamin drugs
-
East China will take $2 billion in oral anti-sugar drugs and East Sunshine drugs to siege Merca East
Time of Update: 2021-01-21
Recently, NMPA official website data show that the Central and Eastern China's Sigletin metformin tablets (I.) category 4 imitation listing applications into the "approval" state, is expected to usher in good news in the near future.
-
Notice of shandong Provincial Market Supervision Bureau on the non-conformity of 2 batches of food products No. 27 of 2019 (Total No. 211)
Time of Update: 2021-01-21
), of which 301 batches of qualified samples (product information see annex 1), non-conforming samples 2 batches (product information see annex 2). the specifics are as follows: Alcohol. , Binzhou City, Yiyijia Brewing Equipment Co. , Ltd
-
Two studies explore the body's unique susceptivity to SARS-CoV-2 variants and vaccines
Time of Update: 2021-01-20
these variants include a special post-translational modification of the rich IgG1 subsype anti-RBD (subject binding domain) antibody, called deyan algae glycosylation.
-
Hengrui IL-2 derivative therapeutic drugs declared clinical
Time of Update: 2021-01-20
Recently, Hengrui Pharmaceuticals announced that its independent research and development in the research PEG modified IL-2 drug SHR-1916 domestic declared clinical trials, has been accepted by CDE contractor, intended for the treatment of advanced malignant tumors.
-
Anti-cancer breakthrough! Lysovirus in conjunction with CAR-T efficacy 1 >2?
Time of Update: 2021-01-20
Recently, scientists at Hope City National Medical Center in the United States combined two immunotherapies, lysovirus and CAR-T cell therapy, to overcome the micro-environment effects of tumors, successfully targeting and eradicating solid tumors
-
Gilead's new shell functional inhibitor lenspavir Phase 2/3 clinical end point!
Time of Update: 2021-01-19
failed treatments (functional monotherapy). of the 24 people randomly assigned to the lensapavir group, the median baseline virus load was 4.2 log10 copies/mL, and 67% of the subjects had a CD4 count below 200/uL. At the end of the 14-day
-
Unrasing the Code of Aging 2 studies in the same period in the journal Nature put forward new ideas for anti-aging therapy
Time of Update: 2021-01-19
The niacinamide adenine dinucleotide, referred to simply as NAD, is a key metabolite of cell energy metabolism and a star in the field of anti-aging in recent years. studies have shown that, as we age, the level of NAD-plus in animals decays
-
Notice of the General Administration of Market Supervision on the Non-conformity of 7 Batches of Food (No. 2 of 2020)
Time of Update: 2021-01-19
exceeded the standard, heavy metal pollution, food additives over-range use, quality indicators are not up to standard and other issues. For non-conforming food found in the sampling, the General Administration of Market Supervision has tasked
-
Engli Net Milestone Phase 3 Clinical: Treatment of Type 2 Diabetes significantly reduces the risk of cardiovascular events
Time of Update: 2021-01-19
in adult patients with type 2 diabetes (T2D) and atherosclerotic cardiovascular disease (ASCVD), jardiance or placebo combined standard care was treated. , Jardiance reduced the overall risk of cardiovascular events (first plus recurrence) compared
-
Shanghai sampling 612 batches of food, zinc gluconate oral solution, such as 2 batches of non-conformity
Time of Update: 2021-01-19
Pharmaceutical Co., Ltd. production, Shanghai Baodao Yuanshentang Big Pharmacy Co., Ltd. sales of Xin brand zinc gluconate oral solution (unqualified item: lead). Regarding the non-conforming products found in the above-mentioned sampling, the Bureau
-
Nat Microbiol: Study reveals characteristics of SARS-CoV-2 infection with primates
Time of Update: 2021-01-19
study is also the first to report that SARS-CoV-2 infection specifically alters lung lymphocytes (T-cells), producing a strong and very specific immune response in macaques that allows animals to remove the virus.
-
2 more than 2 billion injections Koren, Howson's first review
Time of Update: 2021-01-19
.)/glucose (48%) electrolyte injections, pyrethroid injections were evaluated exclusively. Tidecycline is a new broad-spectrum antibiotic developed by Pfizer, which is also active against methicillin-resistant Staphylococcus aureus
-
China's new crown vaccine may be able to effectively resist the SARS-CoV-2 mutant strain
Time of Update: 2021-01-19
Chinese pharmaceutical giant China Pharmaceutical Holdings last week obtained "conditional" approval for its vaccine candidate, and manufacturers said they were confident the vaccine would be effective despite the rapid spread of a new mutation, the SARS-CoV-2 virus.
-
2020 inventory: China's 2 categories of "improved new drugs" analysis, Jiangsu Hengrui, Nanjing Shenghe...
Time of Update: 2021-01-19
developed by Jiangsu Hengrui made 2.1 and 2.2 registration declarations, respectively. NDA varieties, only Nanjing Sheng and Pharmaceutical Co., Ltd.'s zuo nitrosium tablets, approved for production. Table 1.1 2020 Domestic Chemical Drugs 2.1
-
Diabetic combined kidney disease or heart failure patients benefited more from SGLT1/2 inhibitors
Time of Update: 2021-01-18
Screenshot Source: The New England Journal of MedicineSOLOIST trial assesses the risk of death from cardiovascular causes and re-hospitalization and emergency care due to type 2 diabetes and recent heart failure.
-
Science paper details! New research suggests that protective immunity to SARS-CoV-2 lasts eight months or more
Time of Update: 2021-01-18
pathogens to the new coronavirus SARS-CoV-2 can last at least eight months after the initial symptoms of infection appear. results were published online January 6, 2021 in the journal Science under the title "Immunological memory to SARS-CoV-2
-
New anti-inflammatory drugs! AbbVie IL-23 inhibitor Skyrizi treats psoriasis arthritis 2 Phase III studies have been successful!
Time of Update: 2021-01-18
January 07, 2021 // -- AbbVie recently announced positive topline results for two Phase 3 studies (KEEPsAKE-1 and KEEPsAKE-2) evaluating the treatment of active psoriasis arthritis (PsA) adult patients with the new anti-inflammatory drug IL-23 inhibitor Skyrizi (risankizumab).
